Pillars of evidence support future heart failure discoveries

by Marc A. Pfeffer
Published 2021-07-01

Will more complete inhibition of the RAAS with angiotensin receptor blockade improve survival following myocardial infarction?

by Marc A Pfeffer
Published 2000-06-01

Will more complete inhibition of the RAAS with angiotensin receptor blockade improve survival following myocardial infarction?

by Marc A Pfeffer
Published 2000-06-01

Review: Prospects for ARB in the next five years

by Hicham Skali, Marc A Pfeffer
Published 2001-12-01

Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarct...

by Raymond Y Kwong, Bobak Heydari, Yin Ge, Shuaib Abdullah, Kana Fujikura, Kyoichi Kaneko, William S Harris, Michael Jerosch-Herold, Elliott M Antman, Jonathan G Seidman, Marc A Pfeffer
Published 2019-01-01

Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial

by Corrado De Marco, Brian L. Claggett, Simon deDenus, Michael R. Zile, Thao Huynh, Akshay S. Desai, Martin G. Sirois, Scott D. Solomon, Bertram Pitt, Jean L. Rouleau, Marc A. Pfeffer, Eileen O'Meara
Published 2021-04-01

Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)

by Hans-Henrik Parving, Barry M Brenner, John JV McMurray, Dick de Zeeuw, Steven M Haffner, Scott D Solomon, Nish Chaturvedi, Frederik Persson, Maria Nicolaides, Alexia Richard, Zhihua Xiang, Juergen Armbrecht, Marc A Pfeffer
Published 2012-09-01

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial

by Magnus O. Wijkman, Brian Claggett, Rafael Diaz, Hertzel C. Gerstein, Lars Køber, Eldrin Lewis, Aldo P. Maggioni, Emil Wolsk, David Aguilar, Rhonda Bentley-Lewis, John J. McMurray, Jeffrey Probstfield, Matthew Riddle, Jean-Claude Tardif, Scott D. Solomon, Marc A. Pfeffer
Published 2020-10-01

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration

by Jelena P. Seferovic, Rhonda Bentley-Lewis, Brian Claggett, Rafael Diaz, Hertzel C. Gerstein, Lars V. Køber, Francesca C. Lawson, Eldrin F. Lewis, Aldo P. Maggioni, John J. V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Scott D. Solomon, Jean-Claude Tardif, Marc A. Pfeffer
Published 2018-01-01